APA (7th ed.) Citation

Liu, L., Wang, A., Liu, X., Han, S., Sun, Y., Zhang, J., . . . Zhang, Y. (2022). Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer. Journal of Translational Medicine, 20(1), 1. https://doi.org/10.1186/s12967-022-03480-x

Chicago Style (17th ed.) Citation

Liu, Lu, Aihong Wang, Xiaoli Liu, Sai Han, Yu Sun, Junhua Zhang, Lingyu Guo, and Youzhong Zhang. "Blocking TIGIT/CD155 Signalling Reverses CD8+ T Cell Exhaustion and Enhances the Antitumor Activity in Cervical Cancer." Journal of Translational Medicine 20, no. 1 (2022): 1. https://doi.org/10.1186/s12967-022-03480-x.

MLA (9th ed.) Citation

Liu, Lu, et al. "Blocking TIGIT/CD155 Signalling Reverses CD8+ T Cell Exhaustion and Enhances the Antitumor Activity in Cervical Cancer." Journal of Translational Medicine, vol. 20, no. 1, 2022, p. 1, https://doi.org/10.1186/s12967-022-03480-x.